Form 8-K - Current report:
SEC Accession No. 0001493152-26-033662
Filing Date
2026-07-17
Accepted
2026-07-17 08:00:18
Documents
11
Period of Report
2026-07-14
Items
Item 5.07: Submission of Matters to a Vote of Security Holders

Document Format Files

Seq Description Document Type Size
1 8-K form8-k.htm   iXBRL 8-K 46718
  Complete submission text file 0001493152-26-033662.txt   210675

Data Files

Seq Description Document Type Size
2 XBRL SCHEMA FILE cocp-20260714.xsd EX-101.SCH 3035
3 XBRL LABEL FILE cocp-20260714_lab.xml EX-101.LAB 34239
4 XBRL PRESENTATION FILE cocp-20260714_pre.xml EX-101.PRE 22372
14 EXTRACTED XBRL INSTANCE DOCUMENT form8-k_htm.xml XML 3114
Mailing Address 19805 N. CREEK PARKWAY BOTHELL WA 98011
Business Address 19805 N. CREEK PARKWAY BOTHELL WA 98011 (786) 459-1831
Cocrystal Pharma, Inc. (Filer) CIK: 0001412486 (see all company filings)

EIN.: 352528215 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-38418 | Film No.: 261181883
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)